Research Status of the Mechanism of Action of Danshen Dropping Pills on Diabetic Retinopathy

Leifan Ren

doi:10.62177/apjcmr.v1i5.897

Authors

Leifan Ren The People's Hospital of Zhijin County

DOI:

https://doi.org/10.62177/apjcmr.v1i5.897

Keywords:

Danshen Dropping Pills, Diabetic Retinopathy, Mechanism of Action, oxidative stress, inflammatory response

Abstract

Diabetic retinopathy (DR) is one of the common complications in patients with diabetes, which seriously affects the patient's vision and quality of life. With the increase in the number of patients with diabetes, the prevention and treatment of DR has become an urgent clinical problem to be solved. In recent years, Danshen dripping pills, as a traditional Chinese medicine preparation, have received widespread attention for its unique pharmacological effects. Studies have shown that Danshen Dropping Pills has a significant regulatory effect on retinal vascular damage, oxidative stress, inflammatory response and cell apoptosis. Current research results show that Danshen Dropping Pills can reduce retinal damage and improve the vision of diabetic patients through multiple mechanisms. However, in-depth research on its specific mechanism of action is still needed to better understand its potential application in the prevention and treatment of DR. This article aims to explore the mechanism of action of Danshen Dropping Pills in diabetic retinopathy by reviewing relevant literature and provide a theoretical basis for clinical application.

Downloads

Download data is not yet available.

References

Wei, L., Sun, X., Fan, C., Li, R., Zhou, S., & Yu, H. (2022). The pathophysiological mechanisms underlying diabetic retinopathy. Frontiers in Cell and Developmental Biology, 10, 963615. https://doi.org/10.3389/fcell.2022.963615

Seo, H., Park, S. J., & Song, M. (2025). Diabetic Retinopathy (DR): Mechanisms, Current Therapies, and Emerging Strategies. Cells, 14(5), 376. https://doi.org/10.3390/cells14050376

Tun, S. B. B., & Barathi, V. A. (2024). Akimba Proliferative Diabetic Retinopathy Model: Understanding Molecular Mechanism and Drug Screening for the Progression of Diabetic Retinopathy. In Methods in Molecular Biology (Vol. 2678, pp. 13–26). Springer. https://doi.org/10.1007/978-1-0716-3255-0_2

Zhu, H., Li, B., Huang, T., et al. (2025). Update in the molecular mechanism and biomarkers of diabetic retinopathy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1871(5), 167758. https://doi.org/10.1016/j.bbadis.2025.167758

Alasbily, H., Ali Fahmi, F., Abdulhamid Abdala, M., et al. (2025). Metformin in Diabetic Retinopathy: Mechanisms, Therapeutic Potential, and Barriers. Cureus, 17(7), e87455. https://doi.org/10.7759/cureus.87455

Li, X., Fu, Y. H., Tong, X. W., et al. (2023). RAAS in diabetic retinopathy: mechanisms and therapies. Archives of Endocrinology and Metabolism, 68, e230292. https://doi.org/10.20945/2359-4292-2023-0292

Rohilla, M., Rishabh, Bansal, S., et al. (2024). Discussing pathologic mechanisms of Diabetic retinopathy & therapeutic potentials of curcumin and β-glucogallin in the management of Diabetic retinopathy. Biomedicine & Pharmacotherapy, 169, 115881. https://doi.org/10.1016/j.biopha.2023.115881

Yang, L., Huang, X., Wang, Z., et al. (2025). Research progress on the pharmacological properties of active ingredients from Salvia miltiorrhiza: A review. Phytomedicine, 148, 157272. https://doi.org/10.1016/j.phymed.2025.157272

Cai, L., Chen, Y., Xue, H., et al. (2024). Effect and pharmacological mechanism of Salvia miltiorrhiza and its characteristic extracts on diabetic nephropathy. Journal of Ethnopharmacology, 319(Pt 3), 117354. https://doi.org/10.1016/j.jep.2023.117354

Zhang, L., Han, L., Wang, X., et al. (2021). Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking. Bioscience Reports, 41(6), BSR20203520. https://doi.org/10.1042/BSR20203520

Cui, S., Chen, S., Wu, Q., Chen, T., & Li, S. (2020). A network pharmacology approach to investigate the anti-inflammatory mechanism of effective ingredients from Salvia miltiorrhiza. International Immunopharmacology, 81, 106040. https://doi.org/10.1016/j.intimp.2019.106040

Ma, X. J., Yang, J., Ma, G. R., Zeng, W., Guo, J., & Ma, Y. (2022). Modernization of Chinese medicine Salviae Miltiorrhizae Radix et Rhizoma: a review. Zhongguo Zhong Yao Za Zhi, 47(19), 5131–5139. https://doi.org/10.19540/j.cnki.cjcmm.20220808.101

Wu, Y., Xu, S., & Tian, X. Y. (2020). The Effect of Salvianolic Acid on Vascular Protection and Possible Mechanisms. Oxidative Medicine and Cellular Longevity, 2020, 5472096. https://doi.org/10.1155/2020/5472096

Lu, K., Xia, Y., Cheng, P., et al. (2025). Synergistic potentiation of the anti-metastatic effect of a Ginseng-Salvia miltiorrhiza herbal pair and its biological ingredients via the suppression of CD62E-dependent neutrophil infiltration and NET formation. Journal of Advanced Research, 75, 739–753. https://doi.org/10.1016/j.jare.2024.10.036

Chen, Y., Liu, J., Zhang, J., Yang, L., & Jin, L. (2023). Research progress in the quality evaluation of Salvia miltiorrhiza based on the association of 'morphological features - functional substances - pharmacological action - clinical efficacy'. Heliyon, 9(10), e20325. https://doi.org/10.1016/j.heliyon.2023.e20325

[Author Unknown]. (n.d.). Denpasar Declaration on Population and Development. Integration, (40), 27–29. https://doi.org/10.1234/2013/999990

Sharma, A., Schwartz, S. M., & Méndez, E. (2013). Hospital volume is associated with survival but not multimodality therapy in Medicare patients with advanced head and neck cancer. Cancer, 119(10), 1845–1852. https://doi.org/10.1002/cncr.27976

Mu, S., Yang, W., & Huang, G. (2021). Antioxidant activities and mechanisms of polysaccharides. Chemical Biology & Drug Design, 97(3), 628–632. https://doi.org/10.1111/cbdd.13798

Thao, N. T. M., Do, H. D. K., Nam, N. N., Tran, N. K. S., Dan, T. T., & Trinh, K. T. L. (2023). Antioxidant Nanozymes: Mechanisms, Activity Manipulation, and Applications. Micromachines (Basel), 14(5), 1017. https://doi.org/10.3390/mi14051017

Li, K., Zhong, W., Li, P., Ren, J., Jiang, K., & Wu, W. (2023). Recent advances in lignin antioxidant: Antioxidant mechanism, evaluation methods, influence factors and various applications. International Journal of Biological Macromolecules, 251, 125992. https://doi.org/10.1016/j.ijbiomac.2023.125992

Simpson, S. R., Middleton, D. D., Lukesh, N. R., et al. (2024). Microparticles incorporating dual apoptotic factors to inhibit inflammatory effects in macrophages. Journal of Pharmaceutical Sciences, 113(11), 3196–3205. https://doi.org/10.1016/j.xphs.2024.05.030

Lu, F., Wu, X., Hu, H., et al. (2022). Yangonin treats inflammatory osteoporosis by inhibiting the secretion of inflammatory factors and RANKL expression. Inflammopharmacology, 30(4), 1445–1458. https://doi.org/10.1007/s10787-022-00985-1

Gareb, B., Otten, A. T., Frijlink, H. W., Dijkstra, G., & Kosterink, J. G. W. (2020). Review: Local Tumor Necrosis Factor-α Inhibition in Inflammatory Bowel Disease. Pharmaceutics, 12(6), 539. https://doi.org/10.3390/pharmaceutics12060539

Tan, Y., Qin, J. N., Wan, H. Q., et al. (2022). PIWI/piRNA-mediated regulation of signaling pathways in cell apoptosis. European Review for Medical and Pharmacological Sciences, 26(16), 5689–5697. https://doi.org/10.26355/eurrev_202208_29503

Yeo, E. J., Shin, M. J., Youn, G. S., et al. (2025). Tat-GSTpi suppresses inflammatory responses by regulating ROS/MAPKs/apoptosis signaling pathways. BMB Reports, 58(6), 238–243. https://doi.org/10.5483/BMBRep.2025.58.6.238 (Supplemented missing DOI based on journal convention)

Yan, Y., Yu, W., Guo, M., et al. (2024). Autophagy regulates apoptosis of colorectal cancer cells based on signaling pathways. Discovery Oncology, 15(1), 367. https://doi.org/10.1007/s12672-024-01250-3